Bilal Hameed, MD

Hepatologist

Dr. Bilal Hameed is a hepatologist, or liver specialist, who treats patients with liver disease including patients before and after undergoing liver transplants. He is board certified by the American Board of Internal Medicine with a general certificate in internal medicine and a subspeciality in gastroenterology.

Hameed earned a medical degree at Dow Medical College in Pakistan and completed an internal medicine residency at the University of Minnesota. He completed consecutive fellowships at the University of Minnesota and UCSF in gastroenterology and transplant hepatology. He is a member of the American Association for the Study of Liver Diseases, American Gastroenterological Association and American Society of Transplantation. He is the author of numerous peer-reviewed articles and the recipient of many awards and honors in his field. Hameed, who is fluent in the Punjabi and Urdu languages, is an associate professor of medicine at UCSF.

Clinics

Liver Disease and Liver Transplant
350 Parnassus Ave., Suite 300
San Francisco, CA 94143
Phone: (415) 353-2318
Fax: (415) 353-2407

Hours: Monday to Friday
8:30 a.m. – 4:30 p.m.

Liver Transplant Program
400 Parnassus Ave., Third Floor
San Francisco, CA 94143
Phone: (415) 353-1888
Fax: (415) 353-8917

Hours: Tuesdays, 8 a.m. – noon, and Thursdays, 1 - 4 p.m.

Board Certification

Gastroenterology, American Board of Internal Medicine
Transplant Hepatology, American Board of Internal Medicine

Academic Title

Associate Professor

More about Bilal Hameed

Additional Languages

Punjabi
Urdu

Education

Dow School of Medicine 2000

Residencies

University of Minnesota, Internal Medicine 2006

Fellowships

University of Minnesota, Gastroenterology 2009
UCSF Medical Center, Transplant Hepatology 2010

Selected Research and Publications

  1. Azeem N, Ajmera V, Hameed B, Mehta N. Hilar cholangiocarcinoma associated with immunoglobulin G4-positive plasma cells and elevated serum immunoglobulin G4 levels. Hepatol Commun. 2018 Apr; 2(4):349-353.
  2. Stravitz RT, Gottfried M, Durkalski V, Fontana RJ, Hanje AJ, Koch D, Hameed B, Ganger D, Subramanian RM, Bukofzer S, Ravis WR, Clasen K, Sherker A, Little L, Lee WM. Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia. Hepatology. 2018 Mar; 67(3):1003-1013.
  3. Kotwani P, Saxena V, Dodge JL, Roberts J, Yao F, Hameed B. History of marijuana use does not affect outcomes on the liver transplant waitlist. Transplantation. 2018 Jan 10.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.